Trial record 1 of 1 for:    nct01094691
Previous Study | Return to List | Next Study

Haufen Diagnostic Biomarkers of BK Renal Disease

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Volker Nickeleit, MD, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT01094691
First received: March 25, 2010
Last updated: April 9, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)